J’Onco Mentor Version 9.09 — KIDNEY PRIMARY

Desktop version. Mobile app coming.

WHAT IS J’ONCO MENTOR?LUNGBREASTHEAD & NECKPROSTATEENDOMETRIUMLIVERKIDNEYTHYROIDBLADDERCOLON & RECTUMMELANOMA OF SKINPANCREASSTOMACHCNSHEMATOPOIETIC DISORDERSTOP CANCER SITESSTORE MANUALRADIATION GUIDESTATE REPORTABILITYICD-10-CM / SECONDARY DXODS RESOURCES

DIAGNOSIS YEAR

Select the diagnosis year first. J’Onco Mentor uses it to establish the standards cycle and to drive year-sensitive routing in this module.

SEER manual—
NAACCR cycle—
Staging context—
Standards statusSelect year
No diagnosis year selected. Year-dependent schema, staging, SSDI, grade, surgery, and manual guidance should not be assumed.

INTERACTIVE KIDNEY PRIMARY-SITE SELECTOR

Detailed bilateral kidney anatomy with symmetric right and left adrenal glands, renal parenchyma, collecting systems, ureters, vessels and regional lymph nodes

Select the documented site or sites of origin directly on the updated bilateral kidney diagram. The tool will calculate primary-site interpretation and laterality. Kidney parenchyma uses C64.9; renal pelvis uses C65.9; ureter uses C66.9.

SELECTED STRUCTURES
None selected.
PRIMARY SITE RESULT

—

Laterality is read directly from the selected diagram hotspot: anatomical right kidney = Right; anatomical left kidney = Left.

Select one or more anatomic structures.

SITE CODE KEY
C64.9 — Kidney (renal parenchyma)
C65.9 — Renal pelvis / calyceal collecting system
C66.9 — Ureter

KIDNEY HISTOLOGY & SCHEMA ROUTING

Type a code or name, or use the dropdown below. Both controls stay synchronized.
SELECTED HISTOLOGY

This dropdown includes kidney-specific histologies and named RCC variants, while flagging histologies that require a different SEER schema. Rare reportable histologies not listed should be verified in ICD-O-3.2 and current standard-setter updates.

KIDNEY MULTIPLE PRIMARY RULES & CALCULATOR

APPLIES TO C64.9 KIDNEY PARENCHYMA. Renal pelvis C65.9 and ureter C66.9 use the separate Renal Pelvis/Ureter/Bladder/Other Urinary rule set. Apply rules in order and stop at the first rule that applies.

INTERACTIVE KIDNEY MULTIPLE PRIMARY REVIEW

MULTIPLE PRIMARY RESULT

—

Select the case pattern and calculate.

KEY KIDNEY RULES

M1: If it remains unknown whether there is one tumor or multiple tumors after all information sources are exhausted, abstract a single primary.

M2: A single tumor is a single primary.

M3: Multiple tumors in sites whose ICD-O site codes differ at the second, third, and/or fourth character are multiple primaries.

M4: Bilateral nephroblastomas (Wilms tumors) are a single primary regardless of timing.

M5: Tumors in both the right and left kidney are multiple primaries unless pathology proves the contralateral tumor(s) are metastatic from the other kidney.

IMPORTANT KIDNEY NOTES

  • Kidney cortex, medulla, capsule, sinus/hilum and renal parenchyma all remain C64.9; they are not separate C64 subsites.
  • Renal pelvis C65.9 and ureter C66.9 are different primary-site codes and use a different urinary-site rule set.
  • Biomarker differences do not by themselves create multiple primaries.
  • If multiple tumors remain in the same unilateral kidney and no early rule resolves the case, continue through the current Kidney rules.

INTERACTIVE KIDNEY REGIONAL LYMPH NODES & cN CALCULATOR

Kidney anatomy with retroperitoneal lymph node regions
SELECTED REGIONAL NODES
None selected.
No regional nodes → cN0. Any positive regional node → cN1. Named regional node involvement maps to EOD Regional Nodes 300.
CALCULATED CLINICAL N

cN0

No involved regional lymph node groups selected → cN0.

Use Auto for diagram-driven staging, or manually override the Clinical N category when it is documented elsewhere.

AJCC STAGING

PATHOLOGIC STAGING CRITERIA — KIDNEY

Qualifying evidence: Partial or radical nephrectomy generally supports pT assessment of renal tumor size and extension. Regional lymph node pathology supports pN when available. Verify the applicable renal primary and histology chapter.

pT / pN: Assign only categories supported by the actual pathological evidence and the site-specific AJCC rules. A diagnosis-confirming biopsy does not automatically establish a pathological primary tumor category.

pM: Pathologically proven distant metastasis may support pM1 where the chapter permits; AJCC does not use pM0.

Treatment sequence: Distinguish initial pathological classification (pTNM) from post-neoadjuvant classification (ypTNM). Confirm eligibility, histology, staging chapter and diagnosis-year edition before finalizing.

Source / verification: AJCC · SEER tools and manuals. Educational overview only; verify exact chapter-specific criteria in the licensed AJCC manual.

Kidney AJCC staging schema / TNM context

Use the T, N and M controls and site-specific factors below. Verify final AJCC ID, TNM edition and stage group in the approved AJCC/SEER staging system for the diagnosis year.

TNM DROPDOWNS: Each T, N and M option includes its staging description. Auto options remain available where the module can calculate from anatomy, size, extension or lymph-node selections.
IMPORTANT: Clinical T and Pathologic T are separate classifications. Clinical T uses the clinical workup/pretreatment assessment. Pathologic T requires qualifying pathologic classification, usually after resection of the primary tumor. Do not copy cT into pT automatically.

CLINICAL T / N / M

Use the clinical/pretreatment size documented in the diagnostic workup. T1/T2 require a known size when confined to the kidney.

CLINICAL T USED

cTX

CLINICAL N USED

cN0

CLINICAL M USED

cM0

CLINICAL AJCC STAGE GROUP

—

PATHOLOGIC T / N / M

Use the resection/pathology size when pathologic classification criteria are met.

PATHOLOGIC T USED

—

PATHOLOGIC N USED

—

PATHOLOGIC M USED

—

PATHOLOGIC CLASSIFICATION: Do not assign pT merely because a biopsy exists. If pathologic classification criteria are not met, leave the pathologic category not applicable rather than automatically assigning pTX.

EXTENT OF DISEASE (EOD)

100

Confined to kidney / renal capsule / cortex-medulla.

200–600

Regional extension including renal vein/major vessels, renal sinus/perirenal fat, IVC, or extension beyond Gerota fascia depending on exact structure.

700

Further contiguous extension such as aorta, liver, ribs, spleen, stomach.

SUMMARY STAGE 2018

1 — LOCALIZED

Confined to kidney, including capsule/cortex/medulla.

2 / 3 / 4 — REGIONAL

Direct extension only / regional nodes only / both direct extension and regional nodes.

7 — DISTANT

Distant site(s) or distant lymph nodes.

SSDI / GRADE

WHO / ISUP GRADE

Preferred kidney grading uses Grade 1–4 when documented. Assign the highest grade from the primary tumor.

KIDNEY SSDIs

Invasion Beyond Capsule · Ipsilateral Adrenal Gland Involvement · Major Vein Involvement · Sarcomatoid Features.

SURGERY OF PRIMARY SITE — 2026

SURGERY CODE

—

No surgery selected.

SEER 2026: A100–A150 are local destruction procedures with no specimen sent to pathology; A200–A800 have a specimen sent to pathology.

COMMON METASTATIC SITES — KIDNEY

Renal cell carcinoma has a broad hematogenous metastatic pattern.

COMMON

Lung

Common hematogenous site of spread from kidney parenchymal cancers.

COMMON

Bone

Common distant site.

COMMON

Liver

Common distant organ site.

COMMON

Brain

Recognized metastatic site, especially for kidney parenchymal primaries.

COMMON

Adrenal gland

NCI lists adrenal involvement among main sites of kidney cancer metastasis.

Registrar reminder: Direct renal-vein/IVC extension is not the same as a discontinuous distant metastasis. Follow the kidney EOD/AJCC extension rules.

SOURCES

2027 standards cycle: Use the 2027 SEER Program Coding and Staging Manual, Solid Tumor Rules 2027, STORE 2027, NAACCR v27 resources, Summary Stage v3.4, and the current diagnosis-year SEER*RSA/EOD schema as applicable. Historical cases may require prior-year instructions.
\n\n